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Abstract
 
Killer immunoglobulin-like receptors (KIR) bind self–major histocompatibility complex class I
molecules, allowing natural killer (NK) cells to recognize aberrant cells that have down-regulated
class I. NK cells express variable numbers and combinations of highly homologous clonally
restricted 
 
KIR
 
 genes, but uniformly express 
 
KIR2DL4
 
. We show that NK clones express both
 
2DL4
 
 alleles and either one or both alleles of the clonally restricted 
 
KIR
 
 
 
3DL1
 
 and 
 
3DL2
 
genes. Despite allele-independent expression, 
 
3DL1
 
 alleles differed in the core promoter by
only one or two nucleotides. Allele-specific 
 
3DL1
 
 gene expression correlated with promoter
and 5
 
  
 
gene DNA hypomethylation in NK cells in vitro and in vivo. The DNA methylase
inhibitor, 5-aza-2
 
 
 
-deoxycytidine, induced 
 
KIR
 
 DNA hypomethylation and heteroge-
neous expression of multiple 
 
KIR
 
 genes. Thus, NK cells use DNA methylation to main-
tain clonally restricted expression of highly homologous 
 
KIR
 
 genes and alleles.
Key words: killer cells, natural • killer inhibitory receptor • alleles • DNA methylation • 
gene expression regulation
 
Introduction
 
NK cells are antigen-nonspecific lymphocytes that are an
important part of the innate immune system (1). Responding
rapidly to tumor cells, viruses, parasites, and certain bacteria,
NK cells kill the aberrant cells and release a variety of
cytokines. NK cytokines help orchestrate subsequent
adaptive T and B lymphocyte immune responses. To
distinguish aberrant from normal cells, NK cells use a variety
of stimulatory and inhibitory receptors, including the killer
Ig-like receptors (KIRs).
 
*
 
 Inhibitory KIR molecules bind
target cell MHC class I molecules and prevent NK cell
attack on normal cells (2). MHC class I molecules, the
ligands for inhibitory KIR molecules, are extremely poly-
morphic,  determining the variety of peptide antigens
presented to CD8
 
  
 
T cells (3). MHC class I polymorphism
also may enhance NK cell surveillance because inhibitory
clonally restricted KIR molecules bind distinct subsets of
MHC class I molecules (2). For example, KIR 3DL1 binds
the Bw4 subset of HLA-B allotypes. KIR 2DL1 and
2DL2/2DL3 bind complementary sets of HLA-C allotypes.
Clonally restricted 
 
KIR
 
 expression may allow a subset of
NK cells to be activated by virus-infected cells and tumor
cells that have selectively down-regulated specific MHC
class I loci or alleles. HIV-1–infected cells selectively
down-regulate HLA-A and HLA-B molecules while
maintaining HLA-C expression (4), consistent with a
potential role for HLA-B–specific KIR 3DL1/3DS1 receptors
(5). In addition, tumors may selectively down-regulate
specific MHC class I molecules, often HLA-B (6, 7). To
understand NK cell function and regulate NK activity for
therapeutic purposes, it is necessary to determine how
NK cells control 
 
KIR
 
 gene expression.
The 
 
KIR
 
 locus is rapidly evolving, being absent from
rodents and showing striking differences between chim-
panzees and humans (8). The tightly packed 
 
KIR
 
 locus is
highly iterative with extremely high sequence similarity
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between 
 
KIR
 
 genes in both coding and noncoding regions
(9, 10). Indeed, except for the borders and one internal 14-
kb region, the 150-kb 
 
KIR
 
 locus does not have a single dis-
tinctive stretch of more than 100 bp. Despite high se-
quence similarity, 
 
KIR
 
 genes are regulated independently.
 
KIR
 
 gene expression differs between NK cell clones in
both number and identity in a seemingly random pattern
(11). NK cell clones from the same individual may express
anywhere from one to eight 
 
KIR
 
 genes. Once established,
clonally restricted 
 
KIR
 
 expression patterns are quite stable
in mature NK cells grown in vitro.
An exception to the seemingly random 
 
KIR
 
 expression
pattern is 
 
KIR2DL4
 
. This gene is expressed by all NK cell
clones studied thus far and is one of the few human 
 
KIR
 
genes with a direct orthologue in chimpanzees (8). The
2DL4 receptor binds HLA-G nonclassical MHC mole-
cules, whose physiological expression is limited to fetal tro-
phoblast cells (12). In contrast to inhibitory KIR molecules,
2DL4 receptor cross-linking uniquely activates IFN-
 
  
 
secre-
tion by both resting and activated NK cells (13). Thus, it is
predicted that clonally restricted 
 
KIR
 
 and 
 
2DL4
 
 genes are
regulated by distinct mechanisms.
More than 25 yr ago, two groups proposed that DNA
methylation controls tissue-specific gene expression (14, 15).
Consistent with this hypothesis, mammals methylate most
cytosines that are part of the mini-palindrome, CpG. DNA
methylation correlates with poor gene transcription of the
inactive X chromosome of female cells, imprinted genes,
transfected genes, and transgenes (16–19). However, the role
of methylation in controlling tissue-specific gene expression
has been questioned and many tissue-specific genes have hy-
pomethylated promoters and 5
 
  
 
regions regardless of expres-
sion (17–19). Few detailed studies show that promoter
methylation is linked to transcriptional repression of genes in
their natural locations in normal development in vivo.
Therefore, the long-standing hypothesis that DNA
methylation controls tissue-specific gene expression in vivo
remains unproven.
In this report, we investigate whether NK cell clones ex-
press one or both alleles of 
 
KIR
 
 genes. We also investigate
a possible correlation between 
 
KIR
 
 methylation and gene
expression in NK cells in vitro and in vivo. Finally, we test
the hypothesis that 
 
KIR
 
 promoter methylation controls
 
KIR
 
 gene expression.
 
Materials and Methods
 
Cells.
 
Informed consent was obtained and human studies were
approved by the University of Iowa Human Subjects review
board. To enrich NK cells, peripheral blood was incubated with
antibody complexes bispecific for erythrocyte glycophorin A and
leukocytes CD3, CD4, CD19, CD36, and CD66b (RosetteSep™;
StemCell Technologies Inc.). Erythrocyte-leukocyte rosettes were
removed by Ficoll density gradient centrifugation (Sigma-Aldrich).
NK-enriched donor L NK cells were cloned by limiting dilution as
previously described (20) and KIR 3DL1
 
  
 
clones were selected for
additional analysis. Donor K NK cells were sorted for 3DL1
 
 
 
(clones K1–K8) and 3DL1
 
  
 
(clone K9) expression using mAb DX9
or Z27.3.7 and analyzed in bulk or cloned by limiting dilution.
The NK-92 cell line was obtained from StemCell Technologies
Inc. and subcloned as previously described (21). YT-Indy cells
were provided by Z. Brahmi, University of Indiana Medical Cen-
ter, Indianapolis, IN. NK-92 subclones and YT-Indy cells were
treated with 5-aza-2
 
 
 
-deoxycytidine (Aza; Sigma-Aldrich) and an-
alyzed by flow cytometry or cloned as previously described (20,
21). mAbs were obtained commercially (Immunotech or BD Bio-
sciences) or have been described (20).
 
Allele-specific Expression.
 
RNA was isolated and cDNA was
synthesized using random hexamer primers. 3DL1 cDNA was
PCR amplified using locus-specific primers, ttcttggtccagagggccgtt
and ctgtaggtccctgcaagggaaa, and cloned into plasmid. Alleles were
typed by BsaAI and SspI digestion. 
 
KIR
 
 
 
2DL4
 
, 
 
3DL1
 
, and 
 
3DL2
 
allele expression was assessed independently in donor K cells by
PCR amplification of cDNA and DNA sequence analysis, using
primers accttcgcttacagcccg, gggtttcctgtgacagaaacag, cgctgtggtgc-
ctcga, ggtgtgaaccccgacatg, gcccctgctgaaatcagg, and acaactgatagggg-
gagtgagg, respectively. When sufficient RNA was available, NK
cell clones were retested using locus-specific reverse transcription
primers, followed by amplification and sequencing of one or two
separate polymorphic sites, using primers distinct from those used
above. For 3DL1, the reverse transcription primer was gtgtacaa-
gatggtatctgta, the exon 3 PCR primers were ttcttggtccagagggccggt
and ctgtgaccatgatcaccac, and the exon 7–9 PCR primers were
agtggtcatcatcctcttcatc and gtgtacaagatggtatctgta. For 3DL2, the re-
verse transcription primer was cagctgctggttcattggat, the exon 3–4
PCR primers were acaaacccttcctgtctgccc and ctgtgatcacgatgtccagg,
and the exon 7–9 PCR primers were gtatctgcagacacctgcat and
cagctgctggttcattggat. For 2DL4, the reverse transcription primer
was ggaagagtgatgctctaagatgg and the exon 8–9 PCR primers were
aaccaagagcctgcgggac and ggaagagtgatgctctaagatgg. In all cases ana-
lyzed, results agree with those presented in Fig. 1.
 
Promoter Analysis.
 
The 5
 
  
 
RACE technique was performed
using a kit as directed by the manufacturer (Bio-Rad Laboratories).
Gene segments ending upstream of the translation start site of the
 
3DL1
 
, 
 
3DL2
 
, and 
 
2DL4
 
 genes (9) were cloned upstream of the
firefly luciferase reporter gene in the pGL3 plasmid (22). To con-
trol for transfection efficiency, test plasmid was cotransfected with
control 
 
  
 
galactosidase or 
 
Renilla
 
 luciferase plasmid. Luciferase and
 
  
 
galactosidase activity was measured 26–42 h later and test activity
was normalized to control activity as previously described (22).
 
Methylation Analysis.
 
Genomic DNA was treated for 6–19 h
with sodium bisulfite as previously described (23). Bisulfite-
treated DNA was PCR amplified using 
 
3DL1
 
-specific primers
and was cloned and sequenced. In all PCR clones sequenced,
 
 
 
98.8% of random cytosines (not part of CpG dinucleotides)
were converted to thymidines, consistent with adequate bisulfite
treatment. Primers ggttttgttgtaatattagaaatattat and cctctaaac-
ccatatctttacctcca were used for donor K and NK-92. Primers tat-
gttagtatagattttagg and cctctaaacccataactcca were used for donor L.
Alternatively, bisulfite-treated donor K DNA was amplified using
locus-specific primers, cctctaaacccatatctttacctcca and ggttttgttg-
taatattagaaatattat, followed by semi-nested amplification with al-
lele-specific primers, tatgaaaaattttaatggtttattg or ttatgaaaaattttaatg-
gtttatta. Products were analyzed using the methylation-sensitive
single nucleotide primer extension assay as previously described
(24). In brief, after bisulfite treatment and allele-specific PCR,
amplicons were hybridized with selected oligonucleotide prim-
ers. Taq polymerase was added with either 
 
32
 
P-labeled dCTP and
cold dTTP or with 
 
32
 
P-labeled dTTP and cold dCTP in the ab-
sence of other dNTP. Under these conditions, primers were ex-
tended by 0 or 1 nucleotide. Oligonucleotides were separated byT
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PAGE and incorporated radioactivity was quantified using an In-
stant Imager (Packard Instrument Co.).
 
Calculations.
 
The observed fraction of 0.536 hypomethylated
 
3DL1
 
 sequences from donor K–sorted 3DL1
 
  
 
NK cells was used
to estimate the percentage of cells with 
 
3DL1
 
 monoallelic hy-
pomethylation. If x
 
   
 
the number of cells that hypomethylate
one allele, y 
 
  
 
the number of cells that hypomethylate two al-
leles, and 0.0256 (x
 
   
 
y) 
 
  
 
the number of contaminating 3DL1
 
 
 
cells that hypomethylate neither allele, then 0.536 
 
  
 
(x
 
   
 
2y) /
2[x
 
   
 
y 
 
  
 
0.0256(x
 
   
 
y)] Solving this equation indicates that
x
 
   
 
9.05y or that 90.1% of 3DL1
 
  
 
cells were monoallelic and
9.9% were biallelic for 
 
3DL1
 
 hypomethylation.
 
Results
 
KIR Genes May Be Expressed in a Monoallelic or Biallelic
Fashion.
 
To investigate 
 
KIR
 
 allele expression, we iso-
lated NK cell clones from two individuals who are het-
erozygous for 
 
3DL1
 
*
 
001
 
 and 
 
3DL1
 
*
 
002
 
 alleles, formerly
designated 
 
NKAT3
 
 and 
 
NKB1
 
, respectively (25). KIR
3DL1 cDNA fragments were amplified by PCR and
cloned into plasmids. Individual plasmids were typed for
 
3DL1
 
 allele usage with restriction endonucleases, SspI
and BsaAI, which selectively digest 3DL1
 
*
 
001 and
3DL1
 
*
 
002 cDNA, respectively. 3DL1
 
  
 
NK cell clones
from donor L showed three patterns of allele expression:
both 
 
3DL1
 
 alleles, the 
 
3DL1
 
*
 
001
 
 allele only, and the
 
3DL1
 
*002 allele only (Fig. 1 A). For example, 16 of the
NK clone L1 cDNA plasmids analyzed were 3DL1*002
and 14 were 3DL1*001, indicating biallelic expression
(Fig. 1 A). In contrast, all 15 clone L3 cDNA plasmids
were 3DL1*001 and all 27 clone L7 cDNA plasmids were
3DL1*002, indicating monoallelic expression. In donor L
the two 3DL1 alleles are expressed alone or together.
Nine donor K NK cell clones from one cloning experi-
ment (K1–K9) expressed both 3DL1 alleles or the *001
allele alone. Identical results were obtained by a single
nucleotide primer extension assay (26 and unpublished
data) and by DNA sequence analysis of bulk RT-PCR
products (see below). In three biallelic clones, expression
of the 3DL1 alleles was equal (Fig. 1 A), indicating that
3DL1*002 transcription and RNA stability are not defec-
tive in donor K cells. Defective cell surface expression or
antibody binding is unlikely because the donor K cDNA
coding sequence is identical to the prototypic 3DL1*002
cDNA (27 and unpublished data).
Because of the skewed 3DL1 allele distribution in donor K,
we tested an additional six clones from a separate cloning ex-
periment (K10–K15). One NK clone (K10) expressed the
*002 allele only, showing that donor K cells may express this
3DL1 allele in the absence of the *001 allele (Fig. 1 A). As be-
fore, most NK cell clones expressed only one allele. There-
fore,  3DL1 alleles can be expressed monoallelically in NK
cells. The 3DL1 gene is not imprinted because both maternal
and paternal alleles are expressed. Cloned NK cells exhibited
monoallelic 3DL1 expression after 3–5 wk of growth in vitro
to  106 cells, indicating that monoallelic KIR expression is
stable in vitro.
Figure 1. KIR gene expression is monoallelic or biallelic. (A)
Shown for NK clones from donor L (L1–L7) and donor K (K1–K15)
are the number of cDNA clones of each 3DL1 allele. Plasmids were
typed by restriction fragment length polymorphism. (B) Donor K allele-
specific gene expression for 3DL1 ( *002 [  ] and *001),  3DL2
(AMC5 [  ] and NKAT4), and 2DL4 ( KIR-103AS [  ] and KIR-
103LP). Each line shows KIR allele expression by an NK cell clone
(K1–K9). Allele expression was determined by locus-specific PCR
and DNA sequencing.T
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To investigate expression of other KIR alleles, we fur-
ther examined donor K, who is heterozygous at the 3DL1,
3DL2, and 2DL4 loci. After amplification with gene-spe-
cific primers, bulk RT-PCR products were sequenced.
The presence of one or two signals at polymorphic sites in-
dicated monoallelic and biallelic 3DL1 expression, respec-
tively (Fig. 1 B). These results for clones K1–K9 were
completely consistent with the results of the plasmid re-
striction fragment length polymorphism assay. Similar re-
sults were obtained using random cDNA priming or gene-
specific cDNA priming and two different sets of PCR
primers (refer to Materials and Methods). KIR 3DL2 RNA
was detected in all nine donor K clones examined, even
though 3DL2 is expressed at a high level in only a minority
of unselected NK clones (11). We did not quantify KIR
RNA levels and monospecific anti-3DL2 mAb was not
available at the time of analysis. One clone (K9) expressed
3DL1 RNA despite having little or no cell surface protein.
Regardless of possible quantitative variation in RNA levels,
3DL1 and 3DL2 RNA expression was either monoallelic
or biallelic (Fig. 1 B). Except for clone K9, all donor K and
donor L NK clones studied here stained brightly with anti-
3DL1 mAb (unpublished data). This indicates that monoal-
lelic 3DL1 expression is associated with biologically signifi-
cant cell surface expression. NK clones K5, K6, and K7
monoallelically expressed the 3DL1*001 allele in combina-
tion with the AMC5 allele, the NKAT4 allele, or both al-
leles of the nearby 3DL2 gene (Fig. 1 B). Therefore, ex-
pression of a KIR gene on one chromosome does not
necessarily determine whether a closely linked KIR gene
will be expressed from the same or the opposite chromo-
some. In contrast to results with the two clonally restricted
KIR genes, KIR2DL4 expression was biallelic in all nine
NK clones examined (Fig. 1 B). The KIR locus provides
the first example of both monoallelic and biallelic expres-
sion within a single genetic complex.
Characterization of KIR Promoters. The 5  RACE tech-
nique produced a staggered series of clones, suggesting that
the transcription start site is located 37 bp upstream of the
translation start site (unpublished data). To locate the 3DL1
core promoter, we made 5  deletions of a 2.3-kb fragment
that included the entire region upstream of the 3DL1 gene
and extended into the neighboring 2DL4 gene. DNA was
inserted next to the luciferase reporter gene and luciferase
activity was measured 24–48 h after transfection into YT-
Indy NK tumor cells (Fig. 2 A). The results indicate that
the 3DL1 core promoter is 217 bp long relative to the
transcription start site, starting 254 bp upstream of the
translation start site (Fig. 2 A). KIR3DL1 promoter activity
was equivalent to that of the positive control SV-40 virus
promoter/enhancer in YT-Indy NK cells (Fig. 2 A), but
was not detectable in HeLa epithelial cells (unpublished
data). This shows that KIR promoter activity is tissue spe-
cific. A similar analysis showed that the 2DL4 and 3DL2
core promoters were within 262 and 271 bp upstream of
the translation start sites, respectively (unpublished data).
To investigate whether promoter polymorphisms could ac-
count for allele-specific gene expression, we sequenced 429
bp surrounding the 3DL1 promoter. The 3DL1 alleles
were very similar in both donors, with only 1–2 bp interal-
lelic differences in the core promoter and 4 bp interallelic
differences in nearby regions (Fig. 2 B). The single donor K
core promoter polymorphic nucleotide did not affect any
known transcription factor binding site predicted by two
computer search algorithms (unpublished data). Because
the 3DL1 promoter contains a CpG island (28), we investi-
gated whether CpG methylation correlated with allele-spe-
cific KIR expression in NK cells.
KIR3DL1 Allele-specific Gene Expression Correlates with
DNA Hypomethylation. Sodium bisulfite converts cytosine
to uracil, but does not convert 5-methylcytosine, allowing
the bases to be distinguished by PCR amplification, cloning,
and sequencing (29). Five donor L NK clones had monoal-
lelic 3DL1 expression (Fig. 1 A). Regardless of which 3DL1
allele was active in these cells, the promoter and 5  regions of
the expressed allele were almost completely hypomethylated
and the nonexpressed allele was almost uniformly methylated
(Fig. 3 A). In NK clones L1 and L2, both alleles were ex-
pressed and contained completely hypomethylated promot-
ers and 5  regions. To analyze the methylation status in do-
nor K clones, we used a single nucleotide primer extension
assay. This technique assayed bulk PCR populations at one
random (control) cytosine residue and four representative
CpG sites. Clones K2, K3, and K4 expressed both 3DL1 al-
leles and had all four CpG sites in a predominantly hypo-
methylated state. The other donor K clones expressed
Figure 2. Characterization of the 3DL1 promoter. (A) The amount
of reporter luciferase activity directed by 3DL1 promoter constructs of
various lengths is shown relative to the activity directed by the SV-40
promoter/enhancer in an experiment that is typical of three or four
independent trials for each construct. (B) Promoter and 5  gene single
nucleotide polymorphisms in donor L (top) and donor K (bottom)
3DL1*001 and 3DL1*002 alleles (these sequence data are available
from GenBank/EMBL/DDBJ under accession nos. AF457597–9 and
AC0111501.7). The 3DL1*002 alleles are identical in the two donors.
The thick black line denotes the core promoter region, the open box
denotes exon 1, and *represents the translation start site.T
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3DL1*001 but not 3DL1*002. CpG sites in the expressed
3DL1*001 allele were largely hypomethylated, whereas
CpG sites in the nonexpressed 3DL1*002 allele were hyper-
methylated (Fig. 3 B). Despite differences in assay method
and background, promoter and 5  region hypomethylation
correlated with allele-specific 3DL1 expression in donor L
and donor K NK clones.
KIR3DL1 Hypomethylation Correlates with Gene Expres-
sion In Vivo. Cultured cells can adopt DNA methylation
patterns in vitro that may not reflect methylation patterns
in vivo (30). Therefore, we tested whether 3DL1 expres-
sion correlated with promoter and 5  region hypomethyla-
tion in NK cells analyzed directly ex vivo from the same
two donors. CD56  NK cells were enriched by a combina-
tion of negative selection and flow cytometry sorting to
 99.5% purity. Donor K and donor L 3DL1  and 3DL1 
populations were 99.4–98.2% and 97.5–98.9% pure, re-
spectively. DNA was extracted, treated with sodium
bisulfite, PCR amplified, cloned, and sequenced. 3DL1 
peripheral blood NK cells had fully or partially methylated
Figure 3. KIR3DL1 hypomethylation correlates with allele-specific
gene expression. (A) NK cell clones from donor L were analyzed by
DNA sequence analysis of bisulfite-treated DNA. The arrow repre-
sents the transcription start site.   and   represent methylated and
unmethylated CpG sites, respectively. Each row represents a separate
PCR clone. On the left is the NK cell clone name and the expressed
3DL1 allele(s). (B) NK cell clones from donor K were analyzed by
methylation-sensitive single nucleotide primer extension assay. Five
sites were analyzed: one non-CpG control cytosine (C) and four CpG
sites (M1, M4, M6, and M8). M1 is the first CpG site in the amplified
region and lies 5  to the core promoter. M4, M6, and M8 lie within
the core promoter. The fraction of methylated nucleotides at each site
is indicated by the dark segment of each pie chart. NK clones K2–K4
expressed both 3DL1 alleles. NK clones K5–K8 expressed only the
*001 allele.T
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3DL1 genes in 28 out of 29 sequences analyzed (Fig. 4). In
contrast, 3DL1  peripheral blood NK cells contained both
hypomethylated and hypermethylated 3DL1 sequences,
with similar findings for both *001 and *002 alleles (Fig. 4).
Hypermethylation of some sequences from 3DL1  cells
was expected because most NK clones expressed only one
of the two 3DL1 alleles. Similar results were found for the
2DS4 gene that encodes a stimulatory KIR. All nine 2DS4
DNA sequences from 2DS4  donor F NK cells were
heavily methylated. Of 14 sequences from 2DS4  NK cells,
7 were hypomethylated and 7 were hypermethylated (Fig.
4). Thus, KIR DNA hypomethylation correlates with gene
expression in NK cells in vivo.
One DNA clone from sorted 3DL1  cells was com-
pletely hypomethylated. This may indicate that complete
promoter and 5  gene hypomethylation is not sufficient for
3DL1 expression. Alternatively, the hypomethylated DNA
may have come from a contaminating 3DL1  NK cell.
Five DNA clones from 3DL1  cells showed hypermethyla-
tion at one end and hypomethylation at the other end (Fig.
4). This might be due to incomplete gene methylation in
vivo or to PCR recombination in vitro (31). PCR recom-
bination events increase with fragmented template DNA,
which is a byproduct of bisulfite treatment (29). Using al-
lele-specific polymorphisms, we were able to identify
3DL1 *001/*002 recombinant DNA clones in our analysis
of NK cell clones (unpublished data). Two sequences from
3DL1  cells were methylated in the coding region but
largely hypomethylated in the promoter, suggesting that
promoter hypomethylation is not sufficient for high level
3DL1  expression. Although hypomethylation correlated
with 3DL1 expression in vivo and in vitro, methylation
was occasionally incomplete.
KIR Genes Have a Monoallelic Hypomethylation Pattern
in Most Peripheral Blood NK Cells. Analyzing data for
which the most sequence information was available,
53.6% of sequences from donor K 3DL1  NK cells were
hypomethylated (Fig. 4), similar to the 64.3% rate ob-
served in NK cell clones (Fig. 3). A 53.6% 3DL1 hy-
pomethylation rate indicates that 90.1% of 3DL1  NK
cells had only one hypomethylated 3DL1 allele in vivo
(refer to Materials and Methods, Calculations). Results
were even more striking for donor F 2DS4  NK cells.
Based on the 98.9% purity of the sorted cells and the ob-
served 50% 2DS4 hypomethylation rate, we estimate
that 98.9% of circulating 2DS4  NK cells had only one
hypomethylated  2DS4 allele. Although we could not
analyze allele-specific gene expression directly, the
strong correlation between KIR hypomethylation and
gene expression suggests that the great majority of cell
surface KIR  circulating NK cells express only one allele
of the relevant clonally restricted KIR locus.
Methylase Inhibitor Induces KIR Gene Expression. To test
whether transcription is a cause or consequence of DNA
hypomethylation, we treated NK92.10 tumor cells with
Aza, an inhibitor of DNA methylases. Using flow cytome-
Figure 4. KIR3DL1 hypomethylation correlates
with gene expression in vivo. Results with donor
K and donor L 3DL1  and 3DL1  NK cells are
indicated for 3DL1*001 and 3DL1*002 alleles.
Results with donor F 2DS4  and 2DS4  NK cells
are indicated. Because the transcription start site
is not known, the ATG translation start site and
position of the rest of 2DS4 exon 1 are indicated.
The 2DS4 alleles are indistinguishable in the se-
quenced region. Analysis is as described in Fig. 3 A.T
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try, new KIR expression was detected using DX9 anti-
3DL1 mAb and GL183 and EB6 mAbs that cross react with
several other KIR molecules (Fig. 5 A). At the time of
analysis, approximately half of the Aza-treated cells bound
GL183 mAb but only a minority bound either DX9 or
EB6 mAbs. This indicates that DNA methylase inhibition
induced heterogeneous KIR expression. DNA methylase
inhibition also induced KIR gene expression in YT-Indy
NK cells (unpublished data). Induction of cell surface KIR
protein expression was specific because we did not detect
molecules that are made by NK cell subsets (CD16), T cells
(CD3), or B cells (CD19; Fig. 5 A and unpublished data).
CD8 expression was not induced on NK92.10 cells but was
induced on YT-Indy cells (Fig. 5 A and unpublished data).
Next, we addressed whether single cells could be induced
to express multiple KIR molecules, including both stimula-
tory and inhibitory receptors. NK92.35 cells were Aza
treated and analyzed by multicolor flow cytometry using
three anti-KIR mAbs with nonoverlapping specificities.
Most treated NK92.35 cells (95.9%) were induced to ex-
press 3DL1 bound by DX9 mAb (Fig. 5 B). The 3DL1 
cells were electronically gated and analyzed for expression
of 2DS4 (detected by FES172 mAb) and 2DL2, 2DL3, and/
or 2DS2 (detected by GL183 mAb). KIR expression was
heterogeneous. About one third of Aza-treated cells ex-
pressed both inhibitory 3DL1 and stimulatory 2DS4 cell
surface protein (Fig. 5 B). The majority of Aza-treated cells
bound both DX9 and GL183 mAbs and  30% bound all
three mAbs. Thus, DNA methylase inhibition induces NK
cells to express multiple KIR genes, including both inhibi-
tory and stimulatory KIR.
Aza induction of KIR expression may have been due to
demethylation at the KIR locus or at other loci. We wished
to analyze KIR gene demethylation, but KIR expression
was heterogeneous (Fig. 5) and was lost from most cells af-
ter cessation of Aza treatment. Loss of expression was ex-
pected because demethylation is incomplete even with
much higher Aza doses and because methylation spreads
from areas of high methylation into neighboring DNA (32,
33). Therefore, we cloned cells 72 h after drug treatment
and analyzed rare KIR  clones (21). Clone NK92.26.5
maintained  3DL1 expression during several months of
growth in the absence of drug. Target cell HLA-B*2705
specifically inhibited cytolysis by NK92.26.5 cells, show-
ing that the 3DL1 molecule was functional (21). Two
NK92.26.5 sublines were analyzed for 3DL1 allele expres-
sion. Line C expressed both 3DL1 alleles but line Z had
expression biased in favor of the 3DL1*001 allele (Fig. 6
A). The line Z 3DL1*002 allele was hypermethylated and
the 3DL1*001 allele was predominantly hypomethylated,
correlating with RNA expression (Fig. 6 B). Therefore,
DNA methylase inhibition leads to KIR demethylation and
gene expression. Although effects on other genes have not
been ruled out, these results suggest that Aza treatment
demethylated individual KIR genes, directly leading to
KIR expression.
Discussion
The two alleles of most autosomal genes are coordinately
expressed but some autosomal genes are expressed monoal-
lelically. A small number of growth-controlling autosomal
genes are imprinted, with expression being limited to the
maternal or paternal allele. Defects in imprinting cause seri-
ous developmental defects, such as Prader-Willi and Angel-
man syndromes (34). Although not imprinted, several genes
of the immune system are expressed in a monoallelic fashion
(35). It has long been appreciated that lymphocytes typically
express only one functional allele of B cell receptor and
TCR genes. Successful rearrangement and expression of one
B cell receptor or TCR allele usually prevents rearrangement
of the other allele, a phenomenon called allelic exclusion.
Recent direct and indirect evidence indicates that nonrear-
ranging immune system genes are also expressed monoalleli-
cally, such as Ly49 and NKG2A mouse NK cell receptors,
Pax5 transcription factor, and cytokines IL-1A, IL-2, IFN- ,
and IL-4 (35–45). Individual cells may express zero, one, or
two alleles of the Ly49, NKG2A, IL-2, and IL-4 genes (36,
37, 40–45). Most or all of these genes are important in deter-
mining lymphocyte developmental decisions.
Figure 5. Methylase inhibitor induces KIR expression.
(A) NK92.10 cells were grown in the absence (filled
peaks) or presence (open peaks) of 1  M Aza and
analyzed 60 h later by flow cytometry using mAb re-
active with CD16 (3G8), CD8 (3B5), 2DL2, 2DL3,
KIR2DS2 (GL183), 3DL1 (DX9), and 2DL1 and
2DS1(EB6). (B) NK92.35 cells were Aza treated for
72 h and stained for expression of 3DL1 (DX9), 2DS4
(FES172),  and 2DL2, 2DL3, and 2DS2 (GL183).
Untreated NK92.35 cells showed only background
binding of anti-KIR mAb (middle panel and dotted
line on left panel), which was nearly identical to bind-
ing of nonspecific mouse IgG to either untreated or
Aza-treated cells (not depicted). Cells positive for DX9
mAb binding (left panel) were analyzed for FES172
and GL183 binding (right panel). Fluorescence intensity
is shown on a logarithmic scale.T
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KIR molecules recognize MHC class I molecules and
are critical for human NK cell discrimination of normal
from aberrant self. The KIR2DL4 gene is expressed by all
NK clones whereas the other KIR genes are expressed by a
fraction of NK cells in a clonally restricted fashion. Despite
extremely high sequence similarity, clonally restricted KIR
genes appear to be regulated independently. Individual NK
cell clones from the same donor vary in the number and
identity of expressed KIR genes (11). Our data show that
mature NK cells often express only one allele of clonally
restricted KIR genes and that expression of one KIR allele
does not determine whether a separate KIR gene is ex-
pressed from the same chromosome, the opposite chromo-
some, or both chromosomes. Clonally restricted KIR genes
show monoallelic expression in vitro. Hypomethylation of
both KIR alleles was deduced to occur in a small minority
of cell surface KIR  peripheral blood NK cells. While this
manuscript was under review, Santourlidis et al. (47) re-
ported a correlation between KIR hypomethylation and
gene expression. In apparent contrast to our work, San-
tourlidis et al. found that polyclonal NK cells from one do-
nor had almost complete hypomethylation of 3DL1 and
2DL3 genes from sorted KIR  NK cells (47). We cannot
explain these findings, but we point out that our results
with two KIR genes from three donors are consistent with
monoallelic hypomethylation in the majority of sorted NK
cells analyzed directly ex vivo. Based upon the strong cor-
relation between KIR gene hypomethylation and expres-
sion, we propose that circulating NK cells typically express
only one allele of clonally restricted KIR genes in vivo.
Coffman and Reiner (46) postulated that monoallelic ex-
pression reflects the activation of limited subsets of highly
homologous genes by individual lymphocytes in a stochas-
tic manner during development.
T cells express IL-2 and IL-4 genes monoallelically after
relatively weak signaling and biallelically after strong signal-
ing (42, 43, 45). Most in vitro–stimulated NK cell clones
expressed 3DL1 in a monoallelic fashion although the per-
centage of biallelic expression may have been higher
( 33%) than in circulating NK cells.
NK cells sorted directly ex vivo retain a single pattern of
anti-KIR mAb binding after short-term or long-term cul-
ture (20, 48). This shows that NK cell clones remain com-
mitted to specific clonally restricted KIR genes. Our results
extend this finding to individual alleles. NK cell clones
showed unequivocal monoallelic expression of clonally re-
stricted KIR genes after culture for 3–5 wk and growth to
 106 cells. Therefore, clonally restricted KIR allele choice
was stable. In contrast, transgenic T cells that were sorted
for expression of a recombinant marked IL-2 or IL-4 allele
and then recultured could switch expression to the oppo-
site allele (42–44). In these T cells cytokine allele choice
was not stable. The difference in KIR and cytokine allele
stability might be due to differences in activation-depen-
dent gene expression. NK cells constitutively express KIR
proteins. Thus, transcriptional machinery may remain asso-
ciated with the KIR alleles that are continuously active. In
contrast, IL-2 and IL-4 quickly disappear in the absence of
T cell stimulation. With each round of stimulation, the
transcription machinery must be assembled. The IL-4 al-
leles are postulated to be accessible and compete for a limit-
ing supply of transcription factors (42). KIR and cytokine
allele stability also may depend upon lymphocyte maturity.
We studied KIR genes in mature NK cells, whereas IL-2
and IL-4 were studied in naive T cells that continued to
mature with in vitro stimulation (42–44). After multiple
rounds of in vitro stimulation, IL-4 allelic expression pat-
terns became clonally stable (44).
Unlike the clonally restricted KIR genes, 2DL4 is ex-
pressed by all human NK clones (11) in a biallelic fashion
(this study). The KIR locus provides the first example of
both monoallelic and biallelic expression within a single
genetic complex. It is not surprising that 2DL4 and the
clonally restricted KIR genes are regulated differently.
KIR2DL4 has 14 kb of unique upstream DNA and is the
only KIR locus that does not have a distinct minisatellite in
its first intron (9, 10). Despite differences in locus- and al-
lele-specific regulation, the 2DL4 and 3DL1 genes lie less
than 2 kb apart. We speculate that insulators or other barri-
ers prevent transcribed KIR genes from activating their
quiescent neighbors.
Regulation of imprinted genes is complex but methyla-
tion appears to be a key regulator (34). In Prader-Willi syn-
drome/Angelman syndrome, an imprinting center controls
methylation of several maternal alleles. Methylation of an
Figure 6. Methylase inhibitor causes 3DL1 hypomethylation and
allele-specific expression. (A) KIR3DL1 allele expression in Aza-
treated NK92.26.5 lines C and Z. NK92.26 cells were treated with 1
 M Aza for 72 h and then cloned by limiting dilution resulting in the
3DL1  NK92.26.5 clone (reference 21). NK92.26.5 lines C and Z
were grown separately and analyzed for 3DL1 alleles as described in
Fig. 1 A. (B) Methylation analysis of 3DL1 alleles in NK92.26.5 line
Z as described in Fig. 3 A.T
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insulator in the H19/Igf2 locus prevents binding of the
CTCF protein and allows a distant enhancer to act on the
Igf2 promoter. However, it was not clear whether methyla-
tion controls allele-specific expression of nonimprinted
autosomal genes. The KIR locus provides an extremely
stringent test of the hypothesis that methylation controls
tissue-specific gene expression. Except for three noniter-
ated regions, the  150-kb KIR locus does not contain a
single distinctive sequence of  100 bp (9) and KIR allele
promoters are highly similar (this study). Close promoter
region similarity argues that the differentially expressed
KIR alleles do not bind discrete sets of trans-acting pro-
teins. Instead, allele-specific DNA hypomethylation and
gene expression are correlative.
Inhibition of DNA methylases up-regulated expression of
multiple KIR genes, including both inhibitory and stimula-
tory genes. DNA methylase inhibitor treatment also caused
KIR demethylation, linking hypomethylation and gene ex-
pression. Induced KIR expression may have been due to
demethylation of genes that indirectly influenced KIR ex-
pression. It should be pointed out, however, that Aza treat-
ment induced heterogeneous KIR gene expression. Any in-
direct mechanism would have to induce some KIR genes
but not others. Instead, we favor the interpretation that
DNA methylase treatment directly induced KIR gene ex-
pression by demethylating the KIR genes themselves. Ex-
tremely high KIR sequence similarity has been difficult to
reconcile with the observation that individual NK cells ex-
press distinct numbers and combinations of KIR genes (11)
and alleles (this study). Our findings resolve this dilemma,
showing that NK cells use DNA methylation to maintain
stable, clonally restricted allele-specific KIR gene expression.
Few detailed studies show a convincing relationship
between DNA methylation and expression of endogenous
genes in their natural locations in vivo. A widely quoted
study showed that the chicken   globin gene promoter is
demethylated and active in embryonic erythrocytes but
becomes methylated and is not expressed in adult erythro-
cytes (49). Recently, serpinb5 gene methylation was re-
ported to regulate gene expression in breast epithelium
and other tissues (50). In the IFN-  promoter, hypometh-
ylation of the  53 CpG site correlated with gene expres-
sion better than other CpG sites (51, 52). At this site,
nearly all NK cells had an unmethylated CpG and nearly
all monocytes had a methylated CpG, respectively, which
correlated with the presence and absence of IFN-  pro-
duction (51). As assessed using two methylation-sensitive
restriction endonucleases, hypomethylation correlated
with IFN-  expression in naive and mature T cells in
vivo (53). In contrast, the key promoter site was heavily
methylated in some T cells despite robust IFN-  secretion
(54). Although some B lymphocytes did not methylate
the  53 CpG site, they failed to produce IFN-  (51).
Therefore, promoter hypomethylation was neither neces-
sary nor sufficient for IFN-  expression. IL-7–dependent
demethylation correlated with germline transcription of
nonrearranged TCR-  genes in thymocytes (55). How-
ever, studies with rearranging genes are complicated by
the observations that   Ig and TCR-  germline transcrip-
tion arose in methylated DNA (56, 57). Our results show
that promoter and 5  region hypomethylation correlate
with NK cell KIR gene expression in vitro and in vivo.
Most  3DL1 DNA sequences from peripheral blood
3DL1  NK cells showed almost complete promoter and
5  gene methylation. A few 3DL1  NK cell–derived se-
quences showed only partial methylation. This situation
was reminiscent of the general but imperfect correlation
of promoter hypomethylation with IFN-  and IL-3 RNA
expression in mouse T cell clones in vitro (52). Methyla-
tion of specific promoter sites blocks binding of key trans-
acting proteins. In addition, DNA methylation recruits
methyl DNA binding histone deacetylase complexes,
which compact chromatin and make regulatory regions
inaccessible to trans-acting proteins (19). It is likely that
either mechanism may dominate in different settings. The
IL-4 promoter is hypomethylated in all CD4 T cells re-
gardless of gene expression (58). However, 5  portions of
the IL-4 gene become progressively hypomethylated after
Th2 commitment, correlating with increasing IL-4 secre-
tion (58). Similarly, one 3DL1 DNA sequence from pe-
ripheral blood 3DL1  NK cells showed almost complete
promoter hypomethylation but heavy methylation of the
exon 1 and intron 1 sites. This suggests that KIR pro-
moter hypomethylation is not sufficient for gene expres-
sion. KIR gene expression might be inhibited by overall
levels of DNA methylation.
Individual KIR proteins recognize distinct sets of
MHC class I molecules. The ability of tumor cells and
virus-infected cells to selectively down-regulate MHC
class I genes and alleles provides a rationale for indepen-
dent expression of KIR genes. Clonally restricted KIR
expression may allow specific NK cell subsets to be acti-
vated by tumor cells and virus-infected cells that have
selectively down-regulated HLA class I loci or alleles.
Because clonally restricted KIR genes and alleles are
highly homologous, mechanisms that allow independent
expression of KIR genes would be expected to allow in-
dependent expression of KIR alleles. Our results show
that once selected, KIR expression patterns are main-
tained by DNA methylation. An outstanding question is
the relationship between DNA methylation patterns and
KIR expression during NK cell development. IL-2 and
IL-15 induced KIR expression by developing human
NK cells in vitro (59). This suggests the possibility that
cytokine-activated transcription factors induce KIR gene
demethylation. It also seems probable that clonally re-
stricted  KIR expression is achieved by a stochastic
mechanism that operates at the level of individual alleles.
The same mechanisms likely apply to other immune sys-
tem genes that are expressed in a monoallelic fashion,
such as Ly49, NKG2A, and Pax5.
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